Here are the latest quarterly results of LUPIN. For more details, see the LUPIN financial fact sheet and LUPIN share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
3
Mar-26* |
3
Jun-26* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 56,727 | 57,677 | 56,671 | 62,683 | 70,475 | 71,675 | 74,747 | 82,769 | |
| Other income | Rs m | 423 | 537 | 570 | 790 | 900 | 1,147 | 1,407 | 1,303 | |
| Turnover | Rs m | 57,150 | 58,214 | 57,241 | 63,474 | 71,375 | 72,822 | 76,154 | 84,072 | |
| Expenses | Rs m | 43,324 | 44,118 | 43,460 | 45,411 | 47,062 | 49,057 | 49,891 | 58,273 | |
| Gross profit | Rs m | 13,404 | 13,559 | 13,212 | 17,272 | 23,413 | 18,353 | 23,542 | 24,496 | |
| Depreciation | Rs m | 2,569 | 2,715 | 3,932 | 2,990 | 3,168 | 3,130 | 4,468 | 4,529 | |
| Interest | Rs m | 709 | 669 | 891 | 918 | 1,076 | 1,150 | 1,202 | 1,096 | |
| Profit before tax | Rs m | 10,549 | 10,713 | 8,958 | 14,155 | 20,070 | 15,220 | 19,280 | 20,174 | |
| Tax | Rs m | 1,954 | 2,124 | 1,135 | 1,941 | 5,221 | 3,415 | 4,593 | 6,004 | |
| Profit after tax | Rs m | 8,595 | 8,589 | 7,824 | 12,215 | 14,848 | 11,805 | 14,687 | 14,170 | |
| Gross profit margin | % | 23.6 | 23.5 | 23.3 | 27.6 | 33.2 | 25.6 | 31.5 | 29.6 | |
| Effective tax rate | % | 18.5 | 19.8 | 12.7 | 13.7 | 26.0 | 22.4 | 23.8 | 29.8 | |
| Net profit margin | % | 15.2 | 14.9 | 13.8 | 19.5 | 21.1 | 16.5 | 19.6 | 17.1 | |
| Diluted EPS | Rs | 18.8 | 18.8 | 17.1 | 26.7 | 32.5 | 25.8 | 32.1 | 31.0 | |
| Diluted EPS (TTM) | Rs | 58.0 | 63.2 | 72.3 | 81.4 | 95.1 | 102.1 | 117.1 | 121.4 | |
Asian stocks bounced after two days of losses on expectations the Federal Reserve may not need to raise interest rates aggressively next year.